TITLE

Intact and cleaved forms of the urokinase receptor enhance discrimination of cancer from non-malignant conditions in patients presenting with symptoms related to colorectal cancer

AUTHOR(S)
Lomholt, A. F.; Høyer-Hansen, G.; Nielsen, H. J.; Christensen, I. J.
PUB. DATE
September 2009
SOURCE
British Journal of Cancer;9/8/2009, Vol. 101 Issue 6, p992
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background:Colorectal cancer (CRC) is a leading cause of cancer-related morbidity and mortality in developed countries. It is known that early detection results in improved survival, and consequently there is a need for improved diagnostic tools in CRC. The plasma level of soluble urokinase plasminogen activator receptor (suPAR) was proposed as a marker in CRC patients. This study was undertaken to evaluate the individual molecular forms of suPAR as discriminators in a group of patients undergoing endoscopical examination following symptoms related to colorectal cancer.Methods:In a case–control study comprising 308 patients undergoing endoscopical examination following CRC-related symptoms, 77 CRC patients with adenocarcinoma were age and gender matched to: 77 patients with adenomas; 77 with other non-malignant findings, and 77 with no findings. The different uPAR forms were measured in citrate plasma collected before endoscopical examination, using three different Time Resolved – Fluorescence Immuno Assays (TR-FIA's).Results:All soluble uPAR forms were found to be significantly higher in cancer patients than in patients presenting with other non-malignant findings; uPAR(I) P=0.0006, suPAR(I–III) P<0.0001 and suPAR(I–III)+(II–III) P<0.0001, whereas no significant difference was found when performing similar comparisons for patients presenting with adenomas. The odds ratio (OR) for the comparison of uPAR(I) in patients with CRC to subjects with other non-malignant findings was 3.44 (95% CI:1.86–6.37). CRC patients had a mean elevated level of 20.9% (95% CI:10.2–32.6) for suPAR(I–III) and 18.5% (95% CI:9.0–28.8) for suPAR(I–III)+(II–III) compared with subjects with non-malignant findings.Conclusions:The findings confirm reports on increased uPAR expression in cancer patients and in particular elevated levels of suPAR in blood from CRC patients and indicate that suPAR levels in blood are increasing during carcinogenesis. Although none of the measured uPAR forms were cancer specific, our findings suggest that uPAR expression could be useful in the early detection of CRC when combined with other markers and clinical variables.
ACCESSION #
44095403

 

Related Articles

  • PD-0023 VALIDATION STUDY OF A BLOOD-BASED GENE EXPRESSION SIGNATURE FOR COLORECTAL CANCER DETECTION. Xu, Q.; Ye, X.; Wu, F.; Meng, X. // Annals of Oncology;Jun2014, Vol. 25 Issue suppl_2, pii13 

    No abstract available.

  • QuickStats.  // MMWR: Morbidity & Mortality Weekly Report;3/27/2015, Vol. 64 Issue 11, p310 

    A chart is presented that shows the mortality rates of U.S. people with colorectal cancer from 1999 to 2013.

  • Endoscopic follow-up after surgery for colorectal cancer. Loffeld, R. // International Journal of Colorectal Disease;Nov2015, Vol. 30 Issue 11, p1581 

    Objective: Follow-up surgery for colorectal cancer is recommended. The yield of endoscopy is unknown and was therefore studied. Methods: Patients with colorectal cancer in the years 2003, 2004 and 2005 were included. Evaluation was done in July 2014. Results: Cancer was diagnosed in 267...

  • The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial. Hideki Ishikawa; Michihiro Mutoh; Sadao Suzuki; Shinkan Tokudome; Yoshihisa Saida; Takashi Abe; Shozo Okamura; Masahiro Tajika; Takashi Joh; Shinji Tanaka; Shin-ei Kudo; Takahisa Matsuda; Masaki Iimuro; Tomomi Yukawa; Tetsuji Takayama; Yasushi Sato; Kyowon Lee; Shinji Kitamura; Motowo Mizuno; Yasushi Sano // Gut;Nov2014, Vol. 63 Issue 11, p1755 

    Objective: To evaluate the influence of low-dose, enteric-coated aspirin tablets (100 mg/day for 2 years) on colorectal tumour recurrence in Asian patients with single/multiple colorectal tumours excised by endoscopy. Design: A double-blinded, randomised, placebocontrolled multicentre clinical...

  • Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Faivre, J; Tazi, M A; ElMrini, T; Lejeune, C; Benhamiche, A M; Dassonville, F // British Journal of Cancer;2/1/99, Vol. 79 Issue 3/4, p680 

    To estimate the efficacy of screening on colorectal cancer mortality, a population-based case-control study was conducted in well-defined areas of Burgundy (France). Screening by faecal occult blood test prior to diagnosis in cases born between 1914 and 1943 and who died of colorectal cancer...

  • Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Faivre, J; Tazi, M A; ElMrini, T; Lejeune, C; Benhamiche, A M; Dassonville, F // British Journal of Cancer;2/1/99, Vol. 79 Issue 3/4, p680 

    To estimate the efficacy of screening on colorectal cancer mortality, a population-based case-control study was conducted in well-defined areas of Burgundy (France). Screening by faecal occult blood test prior to diagnosis in cases born between 1914 and 1943 and who died of colorectal cancer...

  • Colon cancer in Luxembourg: a national population-based data report, 1988-1998. Scheiden, René; Pescatore, Paul; Wagener, Yolande; Kieffer, Nelly; Capesius, Catherine // BMC Cancer;2005, Vol. 5, p52 

    Background: Over the last two decades time trends in incidence rates of colorectal cancer, changes in the proportions of stage at diagnosis and changes in the anatomic sub-site distribution of colon cancers have been reported in some European countries. In order to determine a strategy for early...

  • Chromoendoscopy with a Standard-Resolution Colonoscope for Evaluation of Rectal Aberrant Crypt Foci. Kowalczyk, Marek; Siermontowski, Piotr; Mucha, Dariusz; Ambroży, Tadeusz; Orłowski, Marcin; Zinkiewicz, Krzysztof; Kurpiewski, Waldemar; Paśnik, Krzysztof; Kowalczyk, Iwona; Pedrycz, Agnieszka // PLoS ONE;2/17/2016, Vol. 11 Issue 2, p1 

    Colorectal cancer (CRC) is the second most common cause of death worldwide. According to the theory by Vogelstein, colorectal carcinogenesis involves a series of successive changes in the normal colonic mucosa, starting with excessive proliferation and focal disorders of intestinal crypts,...

  • Colorectal Cancer Metastasis Presenting as a Testicular Mass: Case Report and Review of the Literature. Ouellette, James R.; Harboe-Schmidt, Jens Erik; Luthringer, Daniel; Brackert, Sandra; Silberman, Allan W. // American Surgeon;Jan2007, Vol. 73 Issue 1, p79 

    Metastatic lesions to the testicle are uncommon. The authors report a testicular mass as the initial manifestation of distant metastasis from colorectal cancer. This case describes a 51-year-old white man who presented with an enlarged right testicle 9 months after undergoing a right...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics